scholarly article | Q13442814 |
P2093 | author name string | Dawkins KD | |
Ward ME | |||
Wong YK | |||
P2860 | cites work | Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 |
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
Infection with Chlamydia pneumoniae in Brooklyn | Q37895177 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events | Q43429735 | ||
Chlamydia pneumoniae and atherosclerosis. | Q33534714 | ||
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae | Q37230432 | ||
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery | Q37879200 | ||
Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection? | Q37879600 | ||
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis | Q37880332 | ||
Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 | ||
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse | Q37881023 | ||
Chronic Chlamydia pneumoniae infection and asthma exacerbations in children | Q37881200 | ||
Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 | ||
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
Chlamydia pneumoniae and acute myocardial infarction in Jerusalem | Q37882349 | ||
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Chlamydia pneumoniae | Q62869737 |
P304 | page(s) | 1435-1439 | |
P577 | publication date | 1999-11-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease | |
P478 | volume | 34 |
Q33968165 | Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells |
Q24791856 | Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review |
Q39365197 | Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory |
Q37855685 | Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum |
Q51726841 | Chlamydia pneumoniae and Cardiovascular Disease. |
Q73311061 | Chlamydia pneumoniae and atherosclerosis |
Q33905858 | Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies |
Q35758705 | Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients? |
Q37865541 | Chlamydia pneumoniae in PBMC: reproducibility of the OMPA nested touchdown PCR. |
Q35586029 | Chlamydia pneumoniae in infrequently examined blood vessels |
Q35913303 | Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae |
Q33971224 | Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography |
Q37866926 | Comparison of five PCR assays for detecting Chlamydophila pneumoniae DNA. |
Q43426679 | Coronary heart disease and Chlamydia pneumoniae DNA in blood mononuclear cells |
Q37873684 | Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions |
Q25255988 | Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques |
Q34004325 | Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas |
Q37873461 | Detection of Chlamydia pneumoniae antigenin PBMNCs of healthy blood donors |
Q37871476 | Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls |
Q37871627 | Detection of Chlamydia pneumoniae deoxyribonucleic acid in blood samples taken from coronary sinus after coronary angioplasty |
Q34946766 | Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae |
Q35538771 | Fibrinogen: biochemistry, epidemiology and determinants |
Q37866783 | Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents |
Q43426255 | Inflammation, infection and coronary artery disease: myths and realities. Special XXXV Conference of the National Congress of the Spanish Society of Cardiology |
Q37869460 | Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study |
Q37869059 | Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity |
Q24531865 | PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids |
Q33935030 | Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells |
Q34465370 | Potential infectious etiologies of atherosclerosis: a multifactorial perspective |
Q37872992 | Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. |
Q37866868 | Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors |
Q37865613 | Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran |
Q37870755 | Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols |
Q37874322 | Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens |
Q37864614 | Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients |
Q34605356 | The role of infection in the genesis and complications of atherosclerosis |